Cited by 2,577Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Candidate gene for the chromosome 1 familial Alzheimer’s disease locus

Levy-Lahad, Ephrat, Wasco, Wilma, Poorkaj, Parvoneh, Romano, Donna M., Oshima, Junko, Pettingell, Warren H., Yu, Chang-en, Jondro, Paul D., Schmidt, Stephen D., Wang, Kai, Crowley, Annette C., Fu, Ying-Hui, Guenette, Suzanne Y., Galas, David, Nemens, Ellen, Wijsman, Ellen M., Bird, Thomas D., Schellenberg, Gerard D., Tanzi, Rudolph E.·1995·Science

DOI 10.1126/science.7638622

Open this paper in CoChat — free account

Abstract

A candidate gene for the chromosome 1 Alzheimer's disease (AD) locus was identified (STM2). The predicted amino acid sequence for STM2 is homologous to that of the recently cloned chromosome 14 AD gene (S182). A point mutation in STM2, resulting in the substitution of an isoleucine for an asparagine (N141l), was identified in affected people from Volga German AD kindreds. This N141l mutation occurs at an amino acid residue that is conserved in human S182 and in the mouse S182 homolog. The presence of missense mutations in AD subjects in two highly similar genes strongly supports the hypothesis that mutations in both are pathogenic.

Integrity signals

Registry

Crossref · 10.1126/science.7638622

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
Self-citation
Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene
Chartier-Harlin, M.-C., Crawford, F., Houlden, H., Warren, A., Hughes, D., Fidani, L., Goate, A., Rossor, M., Roques, P., Hardy, J., et al. (1991) · Nature · doi:10.1038/353844a0 · Cited by 1,214
A mutation in the Amyloid Precursor Protein Associated with Hereditary Alzheimer's Disease
Murrell, J. R., Farlow, M. R., Ghetti, B. F., & Benson, M. D. (1991) · Science · doi:10.1126/science.1925564 · Cited by 1,142
Genetic Linkage Evidence for a Familial Alzheimer's Disease Locus on Chromosome 14
Schellenberg, G. D., Bird, T. D., Wijsman, E. M., Orr, H. T., Anderson, L., Nemens, E. J., White, J. A., Bonnycastle, L. L., Weber, J. L., Alonso, M. E., et al. (1992) · Science · doi:10.1126/science.1411576 · Cited by 957
Self-citation
A Familial Alzheimer's Disease Locus on Chromosome 1
Levy‐Lahad, E., Wijsman, E. M., Nemens, E. J., Anderson, L., Goddard, K. A. B., Weber, J. L., Bird, T. D., & Schellenberg, G. D. (1995) · Science · doi:10.1126/science.7638621 · Cited by 832
Self-citation
Effects of Misspecifying Genetic Parameters in Lod Score Analysis
Clerget‐Darpoux, F., Bonaïti‐Pellié, C., & Hochez, J. (1986) · Biometrics · doi:10.2307/2531059 · Cited by 439
A locus for familial early–onset Alzhelmer's disease on the long arm of chromosome 14, proximal to the α1–antichymotrypsin gene
Mullan, M., Houlden, H., Windelspecht, M., Fidani, L., Lombardi, C., Diaz, P., Rossor, M. N., Crook, R., Hardy, J., Duff, K., et al. (1992) · Nature Genetics · doi:10.1038/ng1292-340 · Cited by 277
Linkage and mutational analysis of familial Alzheimer disease kindreds for the APP gene region.
Kamino, K., Orr, H. T., Payami, H., Wijsman, E. M., Alonso, M. E., Pulst, S. M., Anderson, L., O'dahl, S., Nemens, E. J., & White, J. A. (1992) · PubMed · Cited by 270
Self-citation

Flagged first, then by citations

Show all 25 references

Research works printed but not linked: 3

Bird, T. D., Journal of the American Historical Society of Germans from Russia 49: 1 (1991).
Scheuner D. Soc. Neurosci. Abstr. in press.
Song X.-H. Soc. Neurosci. Abstr. in press.

Sorted by citations

Items 801–900 of 1,015

Concepts of Alzheimer Disease: Biological, Clinical, and Cultural Perspectives
Whitehouse, P. J., Maurer, K., & Ballenger, J. F. (1999) · Cited by 59
Expression of presenilin-1 and -2 mRNAs in rat and Alzheimer's disease brains
Takami, K., Terai, K., Matsuo, A., Walker, D. G., & McGeer, P. L. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01274-7 · Cited by 59
Zinc-Dependent Activation of the Plasma Kinin-Forming Cascade by Aggregated β Amyloid Protein
Shibayama, Y., Joseph, K., Nakazawa, Y., Ghebreihiwet, B., Peerschke, E. I. B., & Kaplan, A. P. (1999) · Clinical Immunology · doi:10.1006/clim.1998.4621 · Cited by 60
Antibody‐based approaches in Alzheimer’s research: safety, pharmacokinetics, metabolism, and analytical tools
Lichtlen, P., & Mohajeri, M. H. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05064.x · Cited by 60
Reanalysis of the first case of Alzheimer’s disease
Graeber, M. B., & Mehraein, P. (1999) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/pl00014167 · Cited by 59
Altered oxidation and signal transduction systems in fibroblasts from Alzheimer patients
Gibson, G. E., Martins, R. N., Blass, J. P., & Gandy, S. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00327-x · Cited by 59
Binding Partners of Alzheimer's Disease Proteins: Are They Physiologically Relevant?
Gassen, G. V., Annaert, W. G., & Broeckhoven, C. V. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0306 · Cited by 62
Immunohistochemical analysis of presenilin‐1 expression in the mouse brain
Moussaoui, S. M., Czech, C., Pradier, L., Blanchard, V., Bonici, B., Gohin, M., Impérato, A., & Revah, F. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00250-5 · Cited by 60
Pharmacological modulation of autophagy for Alzheimer's disease therapy: Opportunities and obstacles
Deng, Z., Dong, Y., Zhou, X., Lu, J.-H., & Yue, Z. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.12.009 · Cited by 58
Metabolic syndrome as a risk factor for Alzheimer's disease: Is Aβ a crucial factor in both pathologies?
Campos-Peña, V., Toral-Rios, D., Becerril-Pérez, F., Sánchez-Torres, C., Delgado-Namorado, Y., Torres-Ossorio, E., Franco-Bocanegra, D., & Carvajal, K. (2017) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6768 · Cited by 58
Amyloid β-Protein Assembly: Differential Effects of the Protective A2T Mutation and Recessive A2V Familial Alzheimer’s Disease Mutation
Zheng, X., Liu, D., Roychaudhuri, R., Teplow, D. B., & Bowers, M. T. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00171 · Cited by 61
Clinical Genetics of Alzheimer’s Disease
Zou, Z., Liu, C., Che, C., & Huang, H. (2014) · BioMed Research International · doi:10.1155/2014/291862 · Cited by 60
Neuroimaging Measures as Endophenotypes in Alzheimer′s Disease
Braskie, M. N., Ringman, J. M., & Thompson, P. M. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/490140 · Cited by 62
Alzheimer's disease-associated polymorphisms in human OGG1 alter catalytic activity and sensitize cells to DNA damage
Jacob, K. D., Hooten, N. N., Tadokoro, T., Lohani, A., Barnes, J., & Evans, M. K. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.05.010 · Cited by 59
Long-term naringin consumption reverses a glucose uptake defect and improves cognitive deficits in a mouse model of Alzheimer's disease
Wang, D., Gao, K., Li, X., Shen, X., Zhang, X., Ma, C., Qin, C., & Zhang, L. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.03.013 · Cited by 59
The Molecular and Neuropathological Consequences of Genetic Risk for Alzheimer's Dementia
Tasaki, S., Gaiteri, C., Mostafavi, S., Jager, P. L. D., & Bennett, D. A. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00699 · Cited by 61
Moonlighting activity of presenilin in plants is independent of γ-secretase and evolutionarily conserved
Khandelwal, A., Chandu, D., Roe, C. M., Kopan, R., & Quatrano, R. S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702038104 · Cited by 61
Systematic genetic study of Alzheimer disease in Latin America: Mutation frequencies of the amyloid ? precursor protein and presenilin genes in Colombia
Arango, D., Cruts, M., Torres, O., Backhovens, H., Serrano, M. L., Villareal, E., Monta�es, P., Matallana, D., Cano, C. A., Broeckhoven, C. V., et al. (2001) · American Journal of Medical Genetics · doi:10.1002/1096-8628(20011001)103:2 · Cited by 59
Apoptosis, Neurotrophic Factors and Neurodegeneration
Dragunow, M., MacGibbon, G. A., Lawlor, P. A., Butterworth, N. J., Connor, B. J., Henderson, C. E., Walton, M. R., Woodgate, A.-M., Hughes, P. E., & Faull, R. L. M. (1997) · Reviews in the Neurosciences · doi:10.1515/revneuro.1997.8.3-4.223 · Cited by 58
Complete Genomic Screen in Late-Onset Familial Alzheimer’s Disease
Pericak‐Vance, M. A., Bass, M. L., Yamaoka, L. H., Gaskell, P. C., Scott, W. K., Terwedow, H. A., Menold, M. M., Conneally, P. M., Small, G. W., Saunders, A. M., et al. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00037-2 · Cited by 58
Molecular mechanisms in Alzheimer's disease and the impact of physical exercise with advancements in therapeutic approaches
Siddappaji, K. K., & Gopal, S. (2021) · AIMS neuroscience · doi:10.3934/neuroscience.2021020 · Cited by 58
Iron and Alzheimer’s Disease: From Pathology to Imaging
Tran, D. Q., DiGiacomo, P., Born, D. E., Georgiadis, M., & Zeineh, M. (2022) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2022.838692 · Cited by 60
Protein Tyrosine Phosphatase 1B (PTP1B): A Comprehensive Review of Its Role in Pathogenesis of Human Diseases
Kołodziej, D., Sobczak, Ł., & Łączkowski, K. Z. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137033 · Cited by 60
Adult hippocampal neurogenesis in aging and Alzheimer's disease
Varela‐Nallar, L., Aránguiz, F. C., Abbott, A. C., Slater, P. G., & Inestrosa, N. C. (2010) · Birth Defects Research Part C Embryo Today Reviews · doi:10.1002/bdrc.20193 · Cited by 60
γ-Secretase and the Intramembrane Proteolysis of Notch
Jorissen, E., & Strooper, B. D. (2010) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(10)92006-1 · Cited by 61
Hyperphosphorylation of JNK-interacting Protein 1, a Protein Associated with Alzheimer Disease
DˈAmbrosio, C., Arena, S., Fulcoli, F. G., Scheinfeld, M. H., Zhou, D., D'adamio, L., & Scaloni, A. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500226-mcp200 · Cited by 59
Genetics of Early-Onset Alzheimer Dementia
Rademakers, R., Cruts, M., & Broeckhoven, C. V. (2003) · The Scientific World JOURNAL · doi:10.1100/tsw.2003.39 · Cited by 58
Genetics and the pathobiology of ageing
Martin, G. M. (1997) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.1997.0161 · Cited by 57
Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer’s Disease: Results from the DIAN Study Group
Su, Y., Blazey, T. M., Owen, C. J., Christensen, J. J., Friedrichsen, K., Joseph-Mathurin, N., Wang, Q., Hornbeck, R. C., Ances, B. M., Snyder, A. Z., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0152082 · Cited by 56
Validation of Aβ1–40 administration into mouse cerebroventricles as an animal model for Alzheimer disease
Takeda, S., Sato, N., Niisato, K., Takeuchi, D., Kurinami, H., Shinohara, M., Rakugi, H., Kano, M., & Morishita, R. (2009) · Brain Research · doi:10.1016/j.brainres.2009.05.035 · Cited by 56
Neurodegeneration and Alzheimer’s disease: the lesson from tauopathies
Sorrentino, G., & Bonavita, V. (2007) · Neurological Sciences · doi:10.1007/s10072-007-0789-x · Cited by 56
Glucose metabolism and PIB binding in carriers of a His163Tyr presenilin 1 mutation
Schöll, M., Almkvist, O., Axelman, K., Stefanova, E. D., Wall, A. E., Westman, E., Långström, B., Lannfelt, L., Graff, C., & Nordberg, A. K. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.08.016 · Cited by 57
γ‐Secretase component presenilin is important for microglia β‐amyloid clearance
Farfara, D., Trudler, D., Segev‐Amzaleg, N., Galron, R., Stein, R., & Frenkel, D. (2010) · Annals of Neurology · doi:10.1002/ana.22191 · Cited by 57
Dissecting Alzheimer's disease pathogenesis in human 2D and 3D models
Cenini, G., Hebisch, M., Iefremova, V., Flitsch, L. J., Breitkreuz, Y., Tanzi, R. E., Kim, D. Y., Peitz, M., & Brüstle, O. (2020) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2020.103568 · Cited by 60
Self-citation
Tau is central in the genetic Alzheimer–frontotemporal dementia spectrum
Dermaut, B., Kumar‐Singh, S., Rademakers, R., Theuns, J., Cruts, M., & Broeckhoven, C. V. (2005) · Trends in Genetics · doi:10.1016/j.tig.2005.09.005 · Cited by 56
Humanin and the Receptors for Humanin
Matsuoka, M., & Hashimoto, Y. (2009) · Molecular Neurobiology · doi:10.1007/s12035-009-8090-z · Cited by 56
The link between cholesterol and Alzheimer's disease
Sjögren, M. J. C., & Blennow, K. (2005) · The World Journal of Biological Psychiatry · doi:10.1080/15622970510029795 · Cited by 60
The last neuronal division: a unifying hypothesis for the pathogenesis of Alzheimer's disease
Nagy, Z. (2005) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2005.tb00485.x · Cited by 56
Abnormal blood vessel development in mice lacking presenilin-1
Nakajima, M., Yuasa, S., Ueno, M., Takakura, N., Koseki, H., & Shirasawa, T. (2003) · Mechanisms of Development · doi:10.1016/s0925-4773(03)00064-9 · Cited by 57
Identification and expression analysis of a potential familial Alzheimer disease gene on chromosome 1 related to AD3.
Li, J., Ma, J., & Potter, H. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.26.12180 · Cited by 56
What determines the molecular composition of abnormal protein aggregates in neurodegenerative disease?
Armstrong, R. A., Lantos, P. L., & Cairns, N. J. (2008) · Neuropathology · doi:10.1111/j.1440-1789.2008.00916.x · Cited by 57
Linkage and Association Study of Late‐Onset Alzheimer Disease Families Linked to 9p21.3
Zuchner, S. L., Gilbert, J. R., Martin, E. R., Guerrero, C. R. L., Xu, P. ‐., Browning, C., Bronson, P. G., Whitehead, P. G., Schmechel, D. E., Haines, J. L., et al. (2008) · Annals of Human Genetics · doi:10.1111/j.1469-1809.2008.00474.x · Cited by 57
The Yeast ER-Intramembrane Protease Ypf1 Refines Nutrient Sensing by Regulating Transporter Abundance
Avci, D., Fuchs, S., Schrul, B., Fukumori, A., Breker, M., Frumkin, I., Chen, C., Biniossek, M. L., Kremmer, E., Schilling, O., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.10.012 · Cited by 55
Recent insights into the molecular genetics of dementia
Rademakers, R., & Rovelet‐Lecrux, A. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.05.005 · Cited by 56
Subcellular Localization of Presenilins: Association with a Unique Membrane Pool in Cultured Cells
Kim, S., Lah, J. J., Thinakaran, G., Levey, A. I., & Sisodia, S. S. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.1999.0280 · Cited by 57
The genetics of Alzheimer’s disease
Schellenberg, G. D., D’Souza, I., & Poorkaj, P. (2000) · Current Psychiatry Reports · doi:10.1007/s11920-000-0061-z · Cited by 55
Self-citation
The role of ATP-binding cassette subfamily A in the etiology of Alzheimer’s disease
Bossaerts, L., Cacace, R., & Broeckhoven, C. V. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00536-w · Cited by 56
Hypothesis review: Alzheimer's overture guidelines
Ferrer, I. (2022) · Brain Pathology · doi:10.1111/bpa.13122 · Cited by 55
Rare variants in β-Amyloid precursor protein (APP) and Parkinson’s disease
Schulte, E. C., Fukumori, A., Mollenhauer, B., Hor, H., Arzberger, T., Perneczky, R., Kurz, A., Diehl‐Schmid, J., Hüll, M., Lichtner, P., et al. (2015) · European Journal of Human Genetics · doi:10.1038/ejhg.2014.300 · Cited by 55
Differentially Expressed Genes in Transgenic Mice Carrying Human Mutant Presenilin-2 (N141I): Correlation of Selenoprotein M with Alzheimer’s Disease
Hwang, D. Y., Cho, J. S., Oh, J. H., Shim, S. B., Jee, S. W., Lee, S. H., Seo, S. J., Lee, S. K., Lee, S. H., & Kim, Y. K. (2005) · Neurochemical Research · doi:10.1007/s11064-005-6787-6 · Cited by 56
Perfusion Magnetic Resonance Imaging in Psychiatry
Théberge, J. (2008) · Topics in Magnetic Resonance Imaging · doi:10.1097/rmr.0b013e3181808140 · Cited by 54
Evidence For and Against a Pathogenic Role of Reduced γ-Secretase Activity in Familial Alzheimer’s Disease
Jayne, T., Newman, M., Verdile, G., Sutherland, G. T., Münch, G. W., Musgrave, I., Nik, S. H. M., & Lardelli, M. T. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151186 · Cited by 54
Mechanisms of neurodegeneration — Insights from familial Alzheimer’s disease
Chávez‐Gutiérrez, L., & Szaruga, M. (2020) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2020.03.005 · Cited by 59
Presenilins in the Developing, Adult, and Aging Cerebral Cortex
Wines-Samuelson, M., & Shen, J. (2005) · The Neuroscientist · doi:10.1177/1073858405278922 · Cited by 54
Chromosome 14 familial Alzheimer's disease: the clinical and neuropathological characteristics of a family with a leucineright-arrowserine (L250S) substitution at codon 250 of the presenilin 1 gene
Harvey, R. J., Ellison, D. W., Hardy, J., Hutton, M., Roques, P. K., Collinge, J., Fox, N. C., & Rossor, M. N. (1998) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.64.1.44 · Cited by 54
Apolipoprotein E Genotype and Deposits of Aβ40 and Aβ42 in Alzheimer Disease
McNamara, M. J., Gómez‐Isla, T., & Hyman, B. T. (1998) · Archives of Neurology · doi:10.1001/archneur.55.7.1001 · Cited by 55
Missense mutations of the PS‐1/S182 gene in german early‐onset Alzheimer's disease patients
Sandbrink, R., Zhang, D., Beyreuther, K. T., Schaeffer, S., Bauer, J., Masters, C. L., & Förstl, H. (1996) · Annals of Neurology · doi:10.1002/ana.410400225 · Cited by 54
S182 protein in Alzheimer's disease neuritic plaques
Wısnıewskı, T., Palha, J. A., Ghiso, J. A., & Frangione, B. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92379-9 · Cited by 54
5 Genetic Regulation of Somite Formation
Rawls, A., Wilson‐Rawls, J., & Olson, E. N. (1999) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(08)60724-3 · Cited by 53
The APOE ε4 exerts differential effects on familial and other subtypes of Alzheimer's disease
Jia, L., Xu, H., Chen, S., Wang, X., Yang, J., Gong, M., Wei, C., Tang, Y., Qu, Q., Chu, L., et al. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12153 · Cited by 53
Molecular Genetics of Early- and Late-Onset Alzheimer’s Disease
Uddin, M. S., Hasana, S., Hossain, M. F., Islam, M. S., Behl, T., Perveen, A., Hafeez, A., & Ashraf, G. M. (2020) · Current Gene Therapy · doi:10.2174/1566523220666201123112822 · Cited by 53
C9ORF72 repeat expansions and other FTD gene mutations in a clinical AD patient series from Mayo Clinic.
Wojtas, A., Heggeli, K., Finch, N. A., Baker, M. C., DeJesus‐Hernandez, M., Younkin, S. G., Dickson, D. W., Graff‐Radford, N. R., & Rademakers, R. (2012) · Europe PMC (PubMed Central) · Cited by 53
Intramembrane Proteolysis in Regulated Protein Trafficking
Lemberg, M. K. (2011) · Traffic · doi:10.1111/j.1600-0854.2011.01219.x · Cited by 54
Effects of CD2-associated protein deficiency on amyloid-β in neuroblastoma cells and in an APP transgenic mouse model
Liao, F., Jiang, H., Srivatsan, S., Xiao, Q., Lefton, K. B., Yamada, K., Mahan, T. E., Lee, J.-M., Shaw, A. S., & Holtzman, D. M. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0006-y · Cited by 53
Role of Trisomy 21 Mosaicism in Sporadic and Familial Alzheimer's Disease
Potter, H., Granic, A., & Caneus, J. (2015) · Current Alzheimer Research · doi:10.2174/156720501301151207100616 · Cited by 54
Modeling neurodegenerative diseases with patient-derived induced pluripotent cells: Possibilities and challenges
Poon, A., Zhang, Y., Chandrasekaran, A., Phanthong, P., Schmid, B., Nielsen, T. T., & Freude, K. (2017) · New Biotechnology · doi:10.1016/j.nbt.2017.05.009 · Cited by 54
Learning from the Past: A Review of Clinical Trials Targeting Amyloid, Tau and Neuroinflammation in Alzheimer’s Disease
Ceyzériat, K., Zilli, T., Millet, P., Frisoni, G. B., Garibotto, V., & Tournier, B. B. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666200304085513 · Cited by 55
Alterations of the Endoplasmic Reticulum (ER) Calcium Signaling Molecular Components in Alzheimer’s Disease
Chami, M., & Checler, F. (2020) · Cells · doi:10.3390/cells9122577 · Cited by 55
A novel mutation (V89L) in the presenilin 1 gene in a family with early onset Alzheimer's disease and marked behavioural disturbances
Queralt, R. (2002) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.72.2.266 · Cited by 53
Alzheimer-associated presenilin-1 gene is induced in gerbil hippocampus after transient ischemia
Tanimukai, H., Imaizumi, K., Kudo, T., Katayama, T., Tsuda, M., Takagi, T., Tohyama, M., & Takeda, M. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00337-9 · Cited by 53
Gene expression of ND4, a subunit of complex I of oxidative phosphorylation in mitochondria, is decreased in temporal cortex of brains of Alzheimer's disease patients
Fukuyama, R., Hatanpaa, K. J., Rapoport, S. I., & Chandrasekaran, K. (1996) · Brain Research · doi:10.1016/0006-8993(95)01517-5 · Cited by 53
Isolation and characterization of Drosophila presenilin homolog
Hong, C., & Koo, E. H. (1997) · Neuroreport · doi:10.1097/00001756-199702100-00017 · Cited by 54
Genetic aspects of susceptibility to air pollution: Table 1
Kleeberger, S. R. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00403003 · Cited by 53
Genome-wide linkage analysis of 723 affected relative pairs with late-onset Alzheimer's disease
Hamshere, M. L., Holmans, P., Avramopoulos, D., Bassett, S. S., Blacker, D., Bertram, L., Wiener, H. W., Rochberg, N., Tanzi, R. E., Myers, A., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm224 · Cited by 53
Self-citation
Pro‐apoptotic effect of presenilin 2 (PS2) overexpression is associated with down‐regulation of Bcl‐2 in cultured neurons
Araki, W., Yuasa, K., Takeda, S., Takeda, K., Shirotani, K., Takahashi, K., & Tabira, T. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00638.x · Cited by 53
Characterization of Drosophila Presenilin and its colocalization with Notch during development
Ye, Y., & Fortini, M. (1998) · Mechanisms of Development · doi:10.1016/s0925-4773(98)00169-5 · Cited by 56
Recent Advances in the Genetics of Alzheimer's Disease and Vascular Dementia with an Emphasis on Gene‐Environment Interactions
Plassman, B. L., & Breitner, J. C. S. (1996) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1996.tb01377.x · Cited by 53
Enhanced generation of intracellular Aβ42 amyloid peptide by mutation of presenilins PS1 and PS2
Takeda, K., Araki, W., & Tabira, T. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2003.03135.x · Cited by 53
[2] TDB: New databases for biological discovery
White, O. R., & Kerlavage, A. R. (1996) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(96)66004-2 · Cited by 53
Genetic analysis of BDNF and TrkB gene polymorphisms in Alzheimer?s disease
Veps�l�inen, S., Ċastrén, E., Helisalmi, S., Iivonen, S., Mannermaa, A., Lehtovirta, M., H�nninen, T., Soininen, H., & Hiltunen, M. O. (2005) · Journal of Neurology · doi:10.1007/s00415-005-0667-5 · Cited by 52
DNA methylation in neurodegenerative disorders: a missing link between genome and environment?
Iraola‐Guzmán, S., Estivill, X., & Rabionet, R. (2011) · Clinical Genetics · doi:10.1111/j.1399-0004.2011.01673.x · Cited by 52
Subcellular Compartment and Molecular Subdomain of β-Amyloid Precursor Protein Relevant to the Aβ42-promoting Effects of Alzheimer Mutant Presenilin 2
Iwata, H., Tomita, T., Maruyama, K., & Iwatsubo, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007989200 · Cited by 52
Primary age-related tauopathy and the amyloid cascade hypothesis: the exception that proves the rule?
Crary, J. F. (2016) · Journal of Neurology and Neuromedicine · doi:10.29245/2572.942x/2016/6.1059 · Cited by 55
Tauists and βaptists United--Well Almost!
Lee, V. M. ‐. (2001) · Science · doi:10.1126/science.1064684 · Cited by 53
Staurosporine‐Induced Activation of Caspase‐3 Is Potentiated by Presenilin 1 Familial Alzheimer's Disease Mutations in Human Neuroglioma Cells
Kovacs, D. M., Mancini, R., Henderson, J., Na, S., Schmidt, S. D., Kim, T., & Tanzi, R. E. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0732278.x · Cited by 53
Self-citation
The new genetics of schizophrenia
McDonald, C., & Murphy, K. C. (2003) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(02)00030-8 · Cited by 52
Early Detection of Alzheimer's Disease by Combining Apolipoprotein E and Neuroimaginga
Small, G. W., Komo, S., Rue, A. L., Saxena, S., Phelps, M. E., Mazziotta, J. C., Saunders, A. M., Haines, J. L., Pericak‐Vance, M. A., & Roses, A. D. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb32600.x · Cited by 52
Neuropathological heterogeneity in Alzheimer’s disease: A study of 80 cases using principal components analysis
Armstrong, R. A., Nochlin, D., & Bird, T. D. (2000) · Neuropathology · doi:10.1046/j.1440-1789.2000.00284.x · Cited by 52
Self-citation
Folding proteins into membranes
Deber, C. M., & Goto, N. K. (1996) · Nature Structural & Molecular Biology · doi:10.1038/nsb1096-815 · Cited by 52
17?-Estradiol attenuates oxidative impairment of synaptic Na+/K+-ATPase activity, glucose transport, and glutamate transport induced by amyloid ?-peptide and iron
Keller, J. N., Germeyer, A., Begley, J. G., & Mattson, M. P. (1997) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19971115)50:4 · Cited by 165
On the metabolism of apolipoprotein E and the Alzheimer diseases
Roses, A. D. (1995) · Experimental Neurology · doi:10.1016/0014-4886(95)90019-5 · Cited by 52
Pilot whole-exome sequencing of a German early-onset Alzheimer's disease cohort reveals a substantial frequency of PSEN2 variants
Blauwendraat, C., Wilke, C., Jansen, I. E., Schulte, C., Simón‐Sánchez, J., Metzger, F. G., Bender, B., Gasser, T., Maetzler, W., Rizzu, P., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.09.016 · Cited by 51
A Unified Hypothesis of Early- and Late-Onset Alzheimer’s Disease Pathogenesis
Atwood, C., & Bowen, R. L. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-143210 · Cited by 56
Aβ Measurement by Enzyme-Linked Immunosorbent Assay
Schmidt, S. D., Mazzella, M. J., Nixon, R. A., & Mathews, P. M. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-551-0_34 · Cited by 54
Self-citation
Intracellular Trafficking of Presenilin 1 Is Regulated by β-Amyloid Precursor Protein and Phospholipase D1
Liu, Y., Zhang, Y., Wang, X., Zhang, H., You, X., Liao, F., & Xu, H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808497200 · Cited by 54
Presenilins and the intramembrane proteolysis of proteins: facts and fiction
Strooper, B. D., & Annaert, W. G. (2001) · Nature Cell Biology · doi:10.1038/ncb1001-e221 · Cited by 52
Amyloid in Alzheimer's disease and prion-related encephalopathies: studies with synthetic peptides
Forloni, G., Tagliavini, F., Bugiani, O., & Salmona, M. (1996) · Progress in Neurobiology · doi:10.1016/0301-0082(96)00013-5 · Cited by 51
Amyloid (Aβ) deposition in chromosome 1–linked Alzheimer's disease: The volga german families
Mann, D. M. A., Iwatsubo, T., Nochlin, D., Sumi, S. M., Levy‐Lahad, E., & Bird, T. D. (1997) · Annals of Neurology · doi:10.1002/ana.410410110 · Cited by 51
Self-citation
Alzheimer's disease-associated presenilin 2 interacts with DRAL, an LIM-domain protein
Tanahashi, H., & Tabira, T. (2000) · Human Molecular Genetics · doi:10.1093/oxfordjournals.hmg.a018919 · Cited by 51
Circadian Disruption Associated with Alzheimer’s Disease
Saeed, Y., & Abbott, S. M. (2017) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-017-0745-y · Cited by 52

Authors: Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., Yu, C.-E., Jondro, P. D., Schmidt, S. D., Wang, K., Crowley, A. C., Fu, Y.-H., Guenette, S. Y., Galas, D., Nemens, E., Wijsman, E. M., Bird, T. D., Schellenberg, G. D., & Tanzi, R. E.
Affiliations: Geriatric Research Education, and Clinical Center (182B), Veterans Affairs Medical Center, Seattle, WA 98108, USA.
Massachusetts General Hospital (US)
United States Department of Veterans Affairs (US)
Darwin Molecular, Bothell, WA 98021, USA.
Genetics and Aging Unit, Massachusetts General Hospital, Charlestown, MA 02129, USA.
University of Washington (US)
ORCID: Oshima, Junko
Yu, Chang-en
Fu, Ying-Hui
Galas, David
Wijsman, Ellen M.
Bird, Thomas D.
Schellenberg, Gerard D.
Tanzi, Rudolph E.
Venue: Science
Publisher: American Association for the Advancement of Science (AAAS)
Published: 1995-08-18
Volume: 269
Issue: 5226
Pages: 973-977
ISSN: 0036-8075 (ISSN-L)
1095-9203
DOI: 10.1126/science.7638622
OpenAlex: W2083633251
Cited by: 2,577
References: 25
Citations by year: 2026: 17 · 2025: 46 · 2024: 66 · 2023: 47 · 2022: 43 · 2021: 65 · 2020: 84 · 2019: 72 · 2018: 65 · 2017: 77 · 2016: 90 · 2015: 63 · 2014: 78 · 2013: 82 · 2012: 83
FWCI: 99.06
Type: journal article
Language: en
Open access: closed
Locations: Science (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5r01ag011899-03)
National Institute on Aging (AG0513C, R01AG011762, R01 AG 11762, R01-AG11899)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: familial Alzheimer's disease, candidate genes, missense mutations, gene homology, pathogenic variants
MeSH terms: Adult, Aged, Alzheimer Disease, Amino Acid Sequence, Base Sequence, Chromosome Mapping, Chromosomes, Human, Pair 1, Cloning, Molecular, Female, Germany, Humans, Lod Score, Male, Membrane Proteins, Middle Aged, Molecular Sequence Data, Mutation, Pedigree, Gene Expression, Point Mutation, DNA, Complementary, Presenilin-2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Candidate gene for the chromosome 1 familial Alzheimer’s disease locus

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks